MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1D
30 iyn, 22:00:00 GMT+2 · EUR
search
Bütün simvollar
| Simvol | Qiymət | Dəyişiklik | % Dəyişiklik |
|---|
Xəbər materialları
Veb mənbələri və xəbər partnyorlarından
Stock Titan
·
29 dəqiqə öncə
A humanoid robot for developers and schools is among four launches planned for Oct. 14.
Foreign Policy Journal
·
54 dəqiqə öncə
Lululemon (NASDAQ: LULU) Faces Brand Reckoning As Sales Slump And Hedge Funds Retreat
Barchart.com
·
3 saat öncə
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Yahoo Finance
·
6 saat öncə
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
Profil
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia